KALA - Kala Pharmaceuticals EPS misses by $0.06 beats on revenue November, 05 2020 07:09 AM Kala Pharmaceuticals Inc. Kala Pharmaceuticals (KALA): Q3 GAAP EPS of -$0.50 misses by $0.06.Revenue of $2.22M (+53.1% Y/Y) beats by $0.21M.Shares +2.07% PM.Press Release For further details see: Kala Pharmaceuticals EPS misses by $0.06, beats on revenue